249 related articles for article (PubMed ID: 11269337)
1. Optimised helper virus-free production of high-quality adeno-associated virus vectors.
Drittanti L; Jenny C; Poulard K; Samba A; Manceau P; Soria N; Vincent N; Danos O; Vega M
J Gene Med; 2001; 3(1):59-71. PubMed ID: 11269337
[TBL] [Abstract][Full Text] [Related]
2. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
3. [Production and purification of helper free recombinant adeno-associated virus 2].
Li GL; Wang RZ; Wang X; Dou WC; Zhang B; Tian SQ; Ren ZY; Su CB
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1255-8. PubMed ID: 12930642
[TBL] [Abstract][Full Text] [Related]
4. Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV).
O'Riordan CR; Lachapelle AL; Vincent KA; Wadsworth SC
J Gene Med; 2000; 2(6):444-54. PubMed ID: 11199265
[TBL] [Abstract][Full Text] [Related]
5. Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines.
Toublanc E; Benraiss A; Bonnin D; Blouin V; Brument N; Cartier N; Epstein AL; Moullier P; Salvetti A
J Gene Med; 2004 May; 6(5):555-64. PubMed ID: 15133766
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing recombinant adeno-associated virus production.
Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
[TBL] [Abstract][Full Text] [Related]
7. An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes.
Kang W; Wang L; Harrell H; Liu J; Thomas DL; Mayfield TL; Scotti MM; Ye GJ; Veres G; Knop DR
Gene Ther; 2009 Feb; 16(2):229-39. PubMed ID: 18923452
[TBL] [Abstract][Full Text] [Related]
8. High throughput production, screening and analysis of adeno-associated viral vectors.
Drittanti L; Rivet C; Manceau P; Danos O; Vega M
Gene Ther; 2000 Jun; 7(11):924-9. PubMed ID: 10849551
[TBL] [Abstract][Full Text] [Related]
9. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
10. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
[TBL] [Abstract][Full Text] [Related]
11. Self-amplification system for recombinant adeno-associated virus production.
Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
[TBL] [Abstract][Full Text] [Related]
12. [Construction of recombinant adeno-associated virus vector co-expressing hVEGF165 and hBMP-7 genes].
Huang X; Shi Z; Wang K; Dang X; Yang P; Yu P
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):807-13. PubMed ID: 18681280
[TBL] [Abstract][Full Text] [Related]
13. Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery.
Chadeuf G; Ciron C; Moullier P; Salvetti A
Mol Ther; 2005 Oct; 12(4):744-53. PubMed ID: 16023415
[TBL] [Abstract][Full Text] [Related]
14. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
[TBL] [Abstract][Full Text] [Related]
15. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
Liu XL; Clark KR; Johnson PR
Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
[TBL] [Abstract][Full Text] [Related]
16. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
[TBL] [Abstract][Full Text] [Related]
17. [hEPO transfer and expression by a recombinant adeno-associated virus vector].
Wu ZJ; Wu XB; Wang H; Lu B; Dong XY; Hou YD
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):176-80. PubMed ID: 12006992
[TBL] [Abstract][Full Text] [Related]
18. [Quality control of recombinant adeno-associated virus type 2/human blood coagulation factor IX].
Gao K; Wang JZ; Rao CM; Wu XB
Yao Xue Xue Bao; 2003 Sep; 38(9):684-9. PubMed ID: 14730919
[TBL] [Abstract][Full Text] [Related]
19. Novel strategy for generation and titration of recombinant adeno-associated virus vectors.
Shiau AL; Liu PS; Wu CL
J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815
[TBL] [Abstract][Full Text] [Related]
20. Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock.
Davidoff AM; Ng CY; Sleep S; Gray J; Azam S; Zhao Y; McIntosh JH; Karimipoor M; Nathwani AC
J Virol Methods; 2004 Nov; 121(2):209-15. PubMed ID: 15381358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
